Abingdon Health (LON:ABDX) Shares Up 35.8% – Here’s Why

Abingdon Health Plc (LON:ABDX) shot up 35.8% during mid-day trading on Tuesday . The company traded as high as GBX 11.29 and last traded at GBX 11.17. 1,147,897 shares were traded during trading, an increase of 405% from the average session volume of 227,213 shares. The stock had previously closed at GBX 8.23.

Abingdon Health Price Performance

The business’s fifty day moving average is GBX 8.28 and its 200-day moving average is GBX 7.15. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The firm has a market cap of £30.13 million, a PE ratio of -14.81 and a beta of 0.12.

Abingdon Health (LON:ABDX) last posted its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.